Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 8:42 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 265–288 of 517 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Sepsis Clear all

Conditions: Blood Stream Infection, Blood Stream Infections, Sepsis, Fungemia, Bacteremia
Interventions: UllCORE BSI Test; Diagnostic Test
Lead sponsor: Deepull Diagnostics S.L.; Industry
Eligibility: Not listed
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 10
States / cities: Orange, California • Tampa, Florida • Baltimore, Maryland + 7 more

Conditions: Nosocomial Infections, Sepsis, Staphylococcal Infections, Candidemia
Interventions: Veronate; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 3 Days to 5 Days
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 85
States / cities: Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 71 more

Conditions: Antibiotic Resistant Infection, Nosocomial Infection, Pathogen Transmission, Nutrition Disorders, Critical Illness, Sepsis
Interventions: Inulin Oral Suspension, Placebo Oral Suspension, Broad-spectrum antibiotics; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Infection
Interventions: Antimicrobial Solution; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Acute Kidney Injury, Septic Shock, Resuscitations
Interventions: Abdominal Perfusion Pressure (APP), Mean Arterial Pressure (MAP); Device
Lead sponsor: Potrero Medical; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 3
States / cities: Little Rock, Arkansas • Atlanta, Georgia

Conditions: Septic Shock
Interventions: Not listed
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 1 Month to 18 Years
Enrollment: 389 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 11
States / cities: Phoenix, Arizona • Los Angeles, California • Washington D.C., District of Columbia + 7 more

Conditions: Sepsis, Systemic Inflammatory Response Syndrome, Infection Mixed, Infection, Bacterial, Infection, Fungal, Infection, Coronavirus, Antibiotic Resistance Genes, Human Genome Analysis
Interventions: Gene Z or other rapid diagnostic techniques developed in our lab (as of 2018 not using Gene Z - now using In-Dx along with other developed techniquesregularly); Device
Lead sponsor: Michigan State University; Other
Eligibility: 18 Years and older
Enrollment: 2,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2032
U.S. locations: 2
States / cities: Lansing, Michigan

Conditions: Septic Shock
Interventions: GIK; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Sepsis
Interventions: Code Sepsis protocol (full implementation); Other
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 180,402 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 3
States / cities: Murray, Utah • Provo, Utah • St. George, Utah

Conditions: Sepsis
Interventions: Treatment of Sepsis; Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Catheter-associated Bloodstream Infections (CLABSI)
Interventions: Sample collection; Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 1 Day to 3 Weeks
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Acute Kidney Injury Due to Sepsis
Interventions: TIN816 70 mg lyophilisate powder, Placebo; Biological · Other
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 316 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 19
States / cities: Birmingham, Alabama • San Francisco, California • Stanford, California + 14 more

Conditions: Pneumonia, Necrotizing Soft Tissue Infection, Intraabdominal Infections, Infection Joint
Interventions: Blue Light; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 65 Years
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Pediatric Sepsis-induced MODS
Interventions: GM-CSF; Drug
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: Up to 17 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 8
States / cities: Los Angeles, California • San Francisco, California • Aurora, Colorado + 5 more

Conditions: Shock, Septic
Interventions: Lactated Ringer, Normal Saline, Plasma-lyte; Drug
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 2 Months to 17 Years
Enrollment: 9,041 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 22
States / cities: Davis, California • Los Angeles, California • San Francisco, California + 19 more

Conditions: Sepsis, Critical Illness
Interventions: Observational; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 1 Month to 19 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Sepsis, Severe Sepsis and Septic Shock
Interventions: Not listed
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 1,320 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Sepsis, Systemic Inflammatory Response Syndrome
Interventions: Not listed
Lead sponsor: Immunexpress; Industry
Eligibility: 18 Years to 95 Years
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 3
States / cities: Los Angeles, California • Atlanta, Georgia • Chicago, Illinois

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Sepsis, Gram-Negative Bacterial Infections, Gram-Positive Bacterial Infections
Interventions: Not listed
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 72 Hours
Enrollment: 615 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 19
States / cities: Birmingham, Alabama • Palo Alto, California • New Haven, Connecticut + 15 more

Conditions: Sepsis, Septic Shock
Interventions: Not listed
Lead sponsor: Bluejay Diagnostics, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 5
States / cities: Gainesville, Florida • Boston, Massachusetts • Winston-Salem, North Carolina + 2 more

Conditions: Sepsis, Trauma, Shock, Acute Kidney Injury
Interventions: Urine collection; Other
Lead sponsor: Denver Health and Hospital Authority; Other
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2013
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: C.Surgical Procedure; Cardiac
Interventions: Acute normovolemic hemodilution, Standard care; Procedure
Lead sponsor: Università Vita-Salute San Raffaele; Other
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 2
States / cities: Oklahoma City, Oklahoma • Charlottesville, Virginia

Conditions: Sepsis
Interventions: Pediatric sepsis screening tool (either algorithmic or manual); Diagnostic Test
Lead sponsor: Computer Technology Associates, Inc.; Industry
Eligibility: 3 Months to 45 Years
Enrollment: 12,961 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2029
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Septic Shock
Interventions: D5W, Thiamine; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Evaluation of Diagnostic Accuracy and Clinical Performance of the UllCORE Bloodstream Infection (BSI) Test

Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants

Inulin for Infections in the Intensive Care Unit

Antimicrobial Catheter Lock Solution for the Treatment of Central Line Associated Bloodstream Infection (CLABSI)

Targeting Abdominal Perfusion Pressure in Septic Shock

Life After Pediatric Sepsis Evaluation

Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

Rapid Administration of Insulin in Sepsis

Effects of Code Sepsis Implementation on Emergency Department (ED) Sepsis Care

Change in MAPSE During Treatment of Sepsis

Catheter Biofilm Microbiome in Infected Neonatal Catheters.

Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI)

The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

GM-CSF for Reversal of immunopAralysis in pediatriC sEpsis-induced MODS Study

Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis

Methionine Metabolism in Parenterally Fed Pediatric Sepsis

Evaluation of CPD MNV as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)

Near Patient Molecular Testing in Sepsis

Early-Onset Sepsis Surveillance Study

Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study

Urinary Heparanase Activity as a Predictor of Acute Kidney Injury in Critically Ill Adults

Acute Normovolemic Hemodilution in High Risk Cardiac Surgery Patients.

Biomarker-enhanced Artificial Intelligence Based Pediatric Sepsis Screening Tool

Thiamine as a Metabolic Resuscitator in Septic Shock